http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-365408-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_404c787d6b2e4d3f135ee391f79199a0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1968-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab47a0efae1c1ab08b7f8b188a7a6991 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296463ea2e505c07fed2367d62570b15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3300352059608e8b9c554226ca1449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e98a0d23d16cca9af9bc48442cae4d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3fa7792e6fcf244e65204f823d1429d |
| publicationDate | 1974-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SE-365408-B |
| abstract | 1,175,468. Pharmaceutical compositions. E. MERCK, A.G. 20 Aug., 1968 [19 Oct., 1967], No. 39730/68. Heading A5B. Pharmaceutical compositions for the treatment of climacteric disorders comprise at least one physiologically compatible salt of oestrone sulphate and at least one physiologically compatible salt of the 3-sulphate of 1, 3, 5 (10)- oestratriene-3, 17#-diol, together with a solid and/or liquid pharmaceutical diluent or carrier. The salts may be alkali metal, alkaline earth metal, aluminium, iron, ammonium or substituted ammonium salts, preferably the sodium salts. The compositions may be administered parenterally as solutions, suspensions, or emulsions or enterally as tablets, dragees, syrups or juices. The composition may contain at least one additional active substance which may be selected from tranquillising substances, vitamins and steroids (e.g. oestrogens, androgens or gestragens such as chlormadinone acetate). Stabilizers, e.g. diethanolamine, N-methyl-glucosamine, sodium citrate, sorensen's buffer (a mixture of disodium hydrogen phosphate and potassium dihydrogen phosphate), and magnesium oxide may be present. |
| priorityDate | 1967-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.